Ghent University Academic Bibliography

Your filters: cql: author="Dolman, Emmy" or (type any "bookEditor issueEditor" and editor="Dolman, Emmy")

Add to list
- Conference Paper
- C3
RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Lisa Depestel (UGent) , Carolina de Carvalho Nunes (UGent) , Liselot Mus (UGent) , Iris Nelen (UGent) , Louis Delhaye (UGent) , Kaylee Keller, Volodimir Olexiouk, Fanny De Vloed (UGent) , Ellen Sanders (UGent) , Aline Eggermont (UGent) , et al.

(2022) OncoPoint Symposium, 8th, Abstracts.
Add to list
- Journal Article
- A1
- open access
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Carolina de Carvalho Nunes (UGent) , Lisa Depestel (UGent) , Liselot Mus (UGent) , Kaylee M. Keller, Louis Delhaye (UGent) , Amber Louwagie (UGent) , Muhammad Rishfi (UGent) , Alex Whale, Neesha Kara, Simon R. Andrews, et al.

(2022) SCIENCE ADVANCES. 8(28).
Add to list
Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

Lucas Moreno, Giuseppe Barone, Steven G. DuBois, Jan Molenaar, Matthias Fischer, Johannes Schulte, Angelika Eggert, Gudrun Schleiermacher, Franki Speleman (UGent) , Louis Chesler, et al.

(2020) EUROPEAN JOURNAL OF CANCER. 136. p.52-68
Add to list
ALK positively regulates MYCN activity through repression of HBP1 expression

Shana Claeys (UGent) , Geertrui Denecker (UGent) , Kaat Durinck (UGent) , Bieke Decaesteker (UGent) , Liselot Mus (UGent) , Siebe Loontiens (UGent) , Suzanne Vanhauwaert (UGent) , Kristina Althoff, Caroline Wigerup, Daniel Bexell, et al.

(2019) ONCOGENE. 38(5). p.2690-2705
Add to list
- Conference Paper
- C3
The RRM2-PHF6 complex protects neuroblastoma cells from DNA damage accumulation to install a replication stress resistance phenotype

Carolina de Carvalho Nunes (UGent) , Kaat Durinck (UGent) , Lisa Depestel (UGent) , Siebe Loontiens (UGent) , Louis Delhaye (UGent) , Sofia Zanotti, Emmy Dolman, Aline Eggermont (UGent) , Bieke Decaesteker (UGent) , Pauline Depuydt, et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
- Conference Paper
- C3
The HBP1 tumour suppressor is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex

Shana Claeys (UGent) , Geertrui Denecker (UGent) , Bieke Decaesteker (UGent) , Els Janssens (UGent) , Candy Kumps (UGent) , Sara De Brouwer (UGent) , Irina Lambertz (UGent) , Annelies Fieuw (UGent) , Suzanne Vanhauwaert (UGent) , Kristina Althoff, et al.

(2017) f-Tales, Abstracts.

Academic Bibliography

RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

ALK positively regulates MYCN activity through repression of HBP1 expression

The RRM2-PHF6 complex protects neuroblastoma cells from DNA damage accumulation to install a replication stress resistance phenotype

The HBP1 tumour suppressor is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex

Contents

Support

Contact